Ascent Partners Fund LLC has reported an increase in its stake in Profusa, Inc., now owning 9.99% of the company’s shares. This move is significant as it reflects Ascent's growing influence in the surgical and medical instruments sector. The filing indicates that Ascent's investment strategy may impact market dynamics and investor sentiment within the industry.

Background

Ascent Partners Fund LLC, incorporated in Delaware, is a limited liability company that primarily engages in investment activities. The company has been actively filing with the SEC, with its most recent filing being a Schedule 13G/A on October 27, 2026. Profusa, Inc., the subject of this filing, is categorized under the SIC code for Surgical & Medical Instruments & Apparatus.

What the Filing Says

The recent SEC filing reveals that Ascent Partners Fund LLC beneficially owns 316,600 shares of Profusa, Inc., which corresponds to 9.99% of the company’s outstanding shares. The filing also notes that Ascent is restricted by a Blocker Amount, limiting its ability to convert certain convertible notes and exercise warrants fully. This limitation is crucial as it impacts Ascent's potential influence over Profusa.

Impact

This update may affect various stakeholders, including existing shareholders of Profusa, Inc., and competitors in the surgical and medical instruments market. Ascent's significant ownership stake could lead to increased scrutiny of Profusa's business strategies and performance. Moreover, the filing indicates that several entities, including Dominion Capital LLC and Eagle Claw Corp., are also involved in this investment, suggesting a broader coalition of interests in Profusa.

What's Next

The filing does not specify what happens next regarding Ascent's investment in Profusa, Inc. However, the ongoing monitoring of the market and potential future filings may provide further insights into the evolving relationship between these companies.